<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03481725</url>
  </required_header>
  <id_info>
    <org_study_id>Pilot STIMULATION (DoD)</org_study_id>
    <secondary_id>NH170005</secondary_id>
    <nct_id>NCT03481725</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study</brief_title>
  <official_title>Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Non-Pharmacologic Alternative for the Treatment of Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Uniformed Services University of the Health Sciences</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Naval Medical Center, San Diego</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Palo Alto VA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Womack Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>SPR Therapeutics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain is usually treated with opioids that have undesirable and sometimes&#xD;
      dangerous side effects (e.g., vomiting and respiratory depression)-and yet over 80% of&#xD;
      patients still experience inadequate pain relief. A novel, non-pharmacologic analgesic&#xD;
      technique-percutaneous peripheral nerve stimulation (PNS)- holds extraordinary potential to&#xD;
      greatly reduce or obviate opioid requirements and concurrently improve analgesia following&#xD;
      painful surgery. This technique involves inserting an insulated electric lead adjacent to a&#xD;
      target nerve through a needle prior to surgery using ultrasound guidance. Following surgery,&#xD;
      a tiny electric current is delivered to the nerve resulting in potent pain control without&#xD;
      any cognitive or adverse systemic side effects whatsoever. The electrical pulse generator&#xD;
      (stimulator) is so small it is simply affixed to the patient's skin. The leads are already&#xD;
      cleared by the US Food and Drug Administration to treat acute (postoperative) pain for up to&#xD;
      60 days; and, since percutaneous PNS may be provided on an outpatient basis, the technique&#xD;
      holds the promise of providing potent analgesia outlasting the pain of surgery-in other&#xD;
      words, the possibility of a painless, opioid-free recovery following surgery.&#xD;
&#xD;
      The current project is a multicenter, randomized, double-masked, placebo-controlled,&#xD;
      parallel-arm clinical pilot study to (1) determine the feasibility and optimize the protocol&#xD;
      of a planned definitive clinical trial; and (2) estimate the treatment effect of percutaneous&#xD;
      PNS on pain and opioid consumption following moderate-to-severely painful ambulatory surgery&#xD;
      compared with usual and customary opioid-based analgesia. This will allow determination of&#xD;
      the required sample size for a subsequent definitive multicenter clinical trial. Combined,&#xD;
      the pilot study and definitive trial have a strong potential to dramatically reduce or&#xD;
      obviate postoperative opioid requirements and their resultant negative effects on both&#xD;
      individuals and society; while concurrently improving analgesia, increasing the ability to&#xD;
      function in daily life, decreasing the risk of transition from acute to chronic pain, and&#xD;
      improving quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot or feasibility study (designated as UG3 by the Department of Defense) which&#xD;
      will be a randomized, double-masked, placebo-controlled, parallel-arm, human subjects pilot&#xD;
      study with two Specific Aims:&#xD;
&#xD;
      Specific Aim 1 (UG3): To determine the feasibility and optimize the protocol of the&#xD;
      Implementation Phase (UH3) multicenter clinical trial that will compare percutaneous PNS with&#xD;
      usual and customary opioid-based analgesia following moderate-to-severely painful ambulatory&#xD;
      surgery.&#xD;
&#xD;
      Specific Aim 2 (UG3): To estimate the treatment effect of percutaneous PNS on pain and opioid&#xD;
      consumption following moderate-to-severely painful ambulatory surgery compared with usual and&#xD;
      customary opioid-based analgesia. This will allow determination of the required sample size&#xD;
      of the definitive multicenter clinical trial of the Implementation Phase (UH3).&#xD;
&#xD;
      Anthropomorphic and demographic characteristics as well as baseline end points will be&#xD;
      recorded/measured, including a pain score at the surgical site using the Numeric Rating Scale&#xD;
      (NRS, 0-10), sensory deficits (measured with von Frey filaments within the cutaneous&#xD;
      distribution of the target nerve), and muscle strength (measured with a pressure transducer).&#xD;
&#xD;
      Shoulder • Rotator cuff repair Brachial plexus trunks (lead &amp; interscalene nerve block)&#xD;
&#xD;
      Knee • Anterior cruciate ligament repair with a patellar autograph Femoral lead &amp; Adductor&#xD;
      canal nerve block&#xD;
&#xD;
      Foot or ankle • Hallux valgus correction or Ankle arthrodesis/ arthroplasty Subgluteal&#xD;
      sciatic lead and Popliteal sciatic nerve block&#xD;
&#xD;
      Insulated leads will be inserted prior to peripheral nerve block administration. The lead&#xD;
      insertion sites will be cleansed with chlorhexidine gluconate and isopropyl alcohol, and a&#xD;
      sterile, fenestrated drape applied. A portable ultrasound paired with either a linear or&#xD;
      curved array transducer within a sterile sleeve will be used for lead insertion. The target&#xD;
      nerve will be imaged in a transverse cross-sectional (short axis) view and a local anesthetic&#xD;
      skin wheal raised lateral to the ultrasound transducer.&#xD;
&#xD;
      A needle and a pre-loaded, monopolar, helically-coiled, insulated lead (SPR Therapeutics,&#xD;
      Cleveland, OH) will be inserted. Using an in-plane ultrasound approach, the needle tip will&#xD;
      be advanced to the target nerve. The lead will be subsequently attached to an external&#xD;
      stimulator (SPR Therapeutics). Accurate lead placement will be confirmed with subject reports&#xD;
      of comfortable sensations over the surgical site without eliciting muscle contractions.&#xD;
&#xD;
      Stimulation parameters will be adjusted to improve stimulation coverage and comfort. Once&#xD;
      optimum parameters have been determined, the needle will be withdrawn over the lead. The lead&#xD;
      will be affixed to the skin with a sterile occlusive dressing. The stimulator will be set to&#xD;
      deliver a range of currents. During their treatment, subjects can control these levels.&#xD;
      Muscle strength will again be tested with the stimulator set for the optimal setting. The&#xD;
      stimulator will be removed until after surgery.&#xD;
&#xD;
      Preoperatively, day of surgery. Subjects will continue to receive usual and customary local&#xD;
      anesthetic-based analgesia. Because percutaneous PNS does not induce a sensory block and&#xD;
      therefore does not provide anesthesia for the surgical procedure itself, we will continue to&#xD;
      provide subjects with a preoperative single-injection local anesthetic-based peripheral nerve&#xD;
      block (20 mL of ropivacaine 0.5% with epinephrine 1:400,000). In addition, surgeons will be&#xD;
      permitted to infiltrate the surgical area with local anesthetic.&#xD;
&#xD;
      Treatment group assignment (randomization). Subjects will be allocated to a treatment only&#xD;
      after confirmation of successfully-inserted electrical leads and surgical procedure&#xD;
      initiation; and will be randomized to one of two possible treatment groups:&#xD;
&#xD;
        1. Current delivered via the electrical lead(s) [Experimental group]&#xD;
&#xD;
        2. No current delivered via the electrical lead(s) [Control group]&#xD;
&#xD;
      Randomization will be stratified by institution and anatomic lead location in a 1:1 ratio and&#xD;
      in randomly chosen block sizes. Treatment group assignment will be conveyed to the enrolling&#xD;
      sites via the same secure web-based system (RedCap) used to collect and collate all&#xD;
      post-intervention endpoints. Stimulators are capable of programming to either (1) pass&#xD;
      electrical current; or, (2) not pass electrical current. Importantly, these 2 modes (active&#xD;
      and sham) are indistinguishable in appearance, and therefore investigators, subjects, and all&#xD;
      clinical staff will be masked to treatment group assignment, with the only exception being&#xD;
      the unmasked individual who programs the stimulator who will not have contact with the&#xD;
      subject following randomization.&#xD;
&#xD;
      Subjects will be informed that often during postoperative active treatment with electrical&#xD;
      current patients do not always have the sensations experienced during preoperative lead&#xD;
      placement and once proper placement is confirmed with comfortable sensations, therapeutic&#xD;
      levels of stimulation may be delivered sub-threshold (below the intensity required for&#xD;
      sensation and still provide relief, which is factual/accurate). This protocol will ensure a&#xD;
      randomized, double/triple-masked, sham/placebo-controlled trial. For the feasibility study&#xD;
      (UG3), unmasking will occur 2 weeks following surgery to allow for protocol revisions, as&#xD;
      necessary (&quot;double masked&quot; during initial data collection). In contrast, for the definitive&#xD;
      pragmatic clinical trial (UH3) unmasking will not occur until statistical analysis for the&#xD;
      entire investigation is complete (termed &quot;triple masked&quot;).&#xD;
&#xD;
      Intraoperative course. The primary surgical anesthetic will be a general anesthetic, spinal&#xD;
      anesthetic (bupivacaine) or exclusively the preoperative single-injection peripheral nerve&#xD;
      block. Anesthetics that are also analgesics such as ketamine will not be used: the only&#xD;
      permitted analgesic will be intravenous fentanyl, which will be minimal since all subjects&#xD;
      will receive a single-injection peripheral nerve block immediately prior to surgery.&#xD;
&#xD;
      Postoperative course. Within the recovery room following surgery, the stimulators will be&#xD;
      attached to the leads and activated, followed by end point assessment. Subjects who had a&#xD;
      spinal anesthetic will have end points recorded following spinal resolution. Operating and&#xD;
      recovery room pharmacologic analgesic requirements will be recorded.&#xD;
&#xD;
      Prior to discharge, subjects and their caretakers will be provided with verbal and written&#xD;
      stimulator/lead instructions and the telephone and pager numbers of a local investigator&#xD;
      available at all times. Subjects will be discharged home with their leads in situ. Subjects&#xD;
      will be also be discharged with a prescription for an immediate-release oral opioid. Subjects&#xD;
      will be contacted by telephone for end point collection (pain and analgesic consumption will&#xD;
      be reported by phone on postoperative days 1, 2, 3, 4, 7, 11, and 15 as well as months 1 and&#xD;
      4). Lead removal will occur on postoperative day 14 (+/- 2 days) by healthcare providers. If&#xD;
      the lead is removed following Day 14, the stimulator will be turned off on Day 14, and&#xD;
      removed subsequently. Following study completion, the results will be mailed electronically&#xD;
      or by the United States Postal Service to all enrolled subjects in written form using&#xD;
      non-technical language.&#xD;
&#xD;
      Outcome measurements (end points). We have selected outcome measures that have established&#xD;
      reliability and validity, with minimal inter-rater discordance, and are recommended for&#xD;
      pain-related clinical trials by the World Health Organization and the Initiative on Methods,&#xD;
      Measurement, and Pain Assessment in Clinical Trials (IMMPACT) consensus statement.&#xD;
      Importantly, nearly all outcome measures are common data elements from the National Institute&#xD;
      of Neurological Disorders and Stroke (NINDS). End points will be evaluated on postoperative&#xD;
      days 0 (baseline), 1, 2, 3, 4, 7, 11, and 15 as well as months 1 and 4).&#xD;
&#xD;
      Demographic and medical history. Subjects will have demographic and anthropomorphic data&#xD;
      collected based on NINDS case report form General Core and Demographics Modules and&#xD;
      Guidelines, including age, sex, height, weight, educational level, employment status, marital&#xD;
      status, and U.S. military service (e.g., none, discharged, active). In addition, the medical&#xD;
      history based on the common data elements of the NINDS Medical, Family, Behavioral History,&#xD;
      History of Disease/Injury Event, and Prior and Concomitant Medications Sub-Domains will be&#xD;
      collected, and include the mechanism of original injury, medications (including analgesics),&#xD;
      previous surgical procedures, comorbidities, existing sensory deficits of the target nerve&#xD;
      distribution, preoperative pain levels measured on a Numeric Rating Scale for pain (including&#xD;
      daily least, average, worst and current), and muscle strength if applicable (measured with a&#xD;
      pressure transducer). In addition, since post-traumatic stress disorder (PTSD) may be&#xD;
      associated with the severity of pain, at baseline we will apply the PTSD Checklist (PCL-C), a&#xD;
      20-item self-report measure reflecting symptoms of PTSD validated in military, Veteran, and&#xD;
      civilian populations.&#xD;
&#xD;
      Data collection. Much of the surgical data from the day of surgery will be extracted from&#xD;
      electronic health records to leverage data collection that occurs in health care delivery&#xD;
      rather than requiring independent research data collection. Subject demographic, surgical and&#xD;
      percutaneous PNS administration data will be uploaded from each enrolling center via the&#xD;
      Internet to a secure, password-protected, encrypted central server (RedCap, Department of&#xD;
      Outcomes Research, Cleveland Clinic, Cleveland, Ohio). All data collection following the day&#xD;
      of enrollment (postoperative day 0)-regardless of enrolling center-will be collected by&#xD;
      telephone from the University of California San Diego. Staff masked to treatment group&#xD;
      assignment will perform all assessments.&#xD;
&#xD;
      UG3 Planning Phase Specific Aims. The investigation described above will accomplish the two&#xD;
      Specific Aims of the UG3 Planning Phase:&#xD;
&#xD;
      Specific Aim 1 (UG3): To determine the feasibility and optimize the protocol of the&#xD;
      Implementation Phase (UH3) multicenter clinical trial that will compare percutaneous PNS with&#xD;
      usual and customary opioid-based analgesia following moderate-to-severely painful ambulatory&#xD;
      surgery.&#xD;
&#xD;
      Specific Aim 2 (UG3): To estimate the treatment effect of percutaneous PNS on pain and opioid&#xD;
      consumption following moderate-to-severely painful ambulatory surgery compared with usual and&#xD;
      customary opioid-based analgesia. This will allow determination of the required sample size&#xD;
      of the definitive multicenter clinical trial of the Implementation Phase (UH3).&#xD;
&#xD;
      ** The primary end points will be cumulative opioid consumption and the mean value of the&#xD;
      &quot;average&quot; daily surgical pain scores (measured with a Numeric Rating Scale) within the first&#xD;
      7 days following surgery (data collected Days 1, 2, 3, 4, and 7). In order to claim that&#xD;
      percutaneous PNS is superior to usual and customary analgesia, at least one of Hypotheses 1&#xD;
      and 2 above must be superior while the other either superior or at least noninferior.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 14, 2018</start_date>
  <completion_date type="Actual">January 7, 2021</completion_date>
  <primary_completion_date type="Actual">September 11, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption During First Postoperative Week</measure>
    <time_frame>Postoperative days 0-7</time_frame>
    <description>Cumulative opioid dose from days 0-7, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point measured in morphine equivalents</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average Pain During First Postoperative Week</measure>
    <time_frame>Postoperative days 0-7</time_frame>
    <description>Mean value of the &quot;average&quot; pain scores measured using the numeric rating scale, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption Individual Time Points</measure>
    <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
    <description>Cumulative opioid dose of previous 24 hours (measured in morphine equivalents)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Pain Inventory, Short Form (Interference Domain)</measure>
    <time_frame>Postoperative days 3, and 7; as well as Months 1 and 4</time_frame>
    <description>The Brief Pain Inventory (short form) interference domain is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale [0 = no interference; 10 = complete interference]: general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The score is calculated by adding the responses for each individual question resulting in a possible range of 0-70 (higher = worse).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Pain at Individual Time Points</measure>
    <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
    <description>Mean of the &quot;average&quot; pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst Pain at Individual Time Points</measure>
    <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
    <description>Median of the worst pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Least Pain at Individual Time Points</measure>
    <time_frame>Postoperative days 3 and 7; as well as Months 1 and 4</time_frame>
    <description>Least pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain. Participants were asked &quot;what was the lowest pain within the last 24 hours measured using the 0 to 10 scale, with 0 equal to no pain and 10 equal to the worst imaginable pain&quot;?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Pain at Individual Time Points</measure>
    <time_frame>Postoperative days 3 and 7; as well as Months 1 and 4</time_frame>
    <description>Current pain scores at the time of the data-collection phone call measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Defense and Veterans Pain Rating Score</measure>
    <time_frame>Postoperative days 3, and 7; as well as Months 1 and 4</time_frame>
    <description>Instrument designed to assess pain level specifically for active duty military and Veteran patient populations. It is a Likert scale from 0 (no pain) to 10 (worst imaginable pain).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Rotator Cuff Repair</condition>
  <condition>Anterior Cruciate Ligament Reconstruction</condition>
  <condition>Ankle Arthrodesis or Arthroplasty</condition>
  <condition>Hallux Valgus Correction</condition>
  <arm_group>
    <arm_group_label>Peripheral Nerve Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ACTIVE percutaneous peripheral nerve stimulation with an ultrasound-guided percutaneous lead (SPR Therapeutics, Cleveland, Ohio) and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that generates electrical current</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>SHAM percutaneous peripheral nerve stimulation with an ultrasound-guided percutaneous lead (SPR Therapeutics, Cleveland, Ohio) and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that does NOT generate electrical current</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio)</intervention_name>
    <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that generates electric current for 14 days</description>
    <arm_group_label>Peripheral Nerve Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable SHAM stimulator (SPR Therapeutics, Cleveland, Ohio)</intervention_name>
    <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that does not generate electric current for 14 days</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age or older&#xD;
&#xD;
          2. undergoing one of the following surgical procedures: rotator cuff repair, anterior&#xD;
             cruciate ligament repair with a patellar autograph, ankle arthrodesis or arthroplasty,&#xD;
             hallux valgus correction&#xD;
&#xD;
          3. with a planned single-injection peripheral nerve block for postoperative analgesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. chronic analgesic use including opioids (daily use within the 2 weeks prior to surgery&#xD;
             and duration of use &gt; 4 weeks)&#xD;
&#xD;
          2. neuro-muscular deficit of the target nerve(s)&#xD;
&#xD;
          3. compromised immune system based on medical history (e.g., immunosuppressive therapies&#xD;
             such as chemotherapy, radiation, sepsis, infection), or other conditions that places&#xD;
             the subject at increased risk&#xD;
&#xD;
          4. implanted spinal cord stimulator, cardiac pacemaker/defibrillator, deep brain&#xD;
             stimulator, or other implantable neurostimulator whose stimulus current pathway may&#xD;
             overlap&#xD;
&#xD;
          5. history of bleeding disorder&#xD;
&#xD;
          6. antiplatelet or anticoagulation therapies other than aspirin due to the risk of&#xD;
             bleeding with a 20-gauge insertion needle&#xD;
&#xD;
          7. allergy to skin-contact materials (occlusive dressings, bandages, tape etc.)&#xD;
&#xD;
          8. incarceration&#xD;
&#xD;
          9. pregnancy&#xD;
&#xD;
         10. chronic pain of greater than 3 months of any severity in an anatomic location other&#xD;
             than the surgical extremity&#xD;
&#xD;
         11. anxiety disorder&#xD;
&#xD;
         12. history of substance abuse&#xD;
&#xD;
         13. inability to contact the investigators during the treatment period, and vice versa&#xD;
             (e.g., lack of telephone access).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian M Ilfeld, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University California San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Womack Army medical Center</name>
      <address>
        <city>Fort Bragg</city>
        <state>North Carolina</state>
        <zip>28310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>February 24, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 18, 2021</results_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Brian M. Ilfeld, MD, MS</investigator_full_name>
    <investigator_title>Professor of Anesthesiology, In Residence</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hallux Valgus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coal Tar</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 12, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03481725/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Peripheral Nerve Stimulation</title>
          <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
        </group>
        <group group_id="P2">
          <title>Sham</title>
          <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Peripheral Nerve Stimulation</title>
          <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
        </group>
        <group group_id="B2">
          <title>Sham</title>
          <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="65"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57" spread="16"/>
                    <measurement group_id="B2" value="55" spread="16"/>
                    <measurement group_id="B3" value="56" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="172" spread="11"/>
                    <measurement group_id="B2" value="174" spread="10"/>
                    <measurement group_id="B3" value="173" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80" spread="16"/>
                    <measurement group_id="B2" value="86" spread="20"/>
                    <measurement group_id="B3" value="83" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" spread="4"/>
                    <measurement group_id="B2" value="29" spread="5"/>
                    <measurement group_id="B3" value="28" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years of education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17" spread="3"/>
                    <measurement group_id="B2" value="16" spread="3"/>
                    <measurement group_id="B3" value="17" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Single</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Currently Married</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Others (separated and widowed)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Military Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Civilian (never in military)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Veteran</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Active Duty</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Enrolling Center</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Cedars-Sinai</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>University California San Diego</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Naval Medical Center San Diego</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walter Reed National Military Medical Center</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Womack Army Medical Center</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical Procedure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Rotator cuff repair</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anterior cruciate ligament reconstruction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ankle arthrodesis</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ankle arthroplasty</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hallux valgus</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical side</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Left</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>General anesthetic</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption During First Postoperative Week</title>
        <description>Cumulative opioid dose from days 0-7, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point measured in morphine equivalents</description>
        <time_frame>Postoperative days 0-7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE percutaneous peripheral nerve stimulation with an ultrasound-guided percutaneous lead (SPR Therapeutics, Cleveland, Ohio) and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that generates electrical current&#xD;
ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio): ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that generates electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM percutaneous peripheral nerve stimulation with an ultrasound-guided percutaneous lead (SPR Therapeutics, Cleveland, Ohio) and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that does NOT generate electrical current&#xD;
SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable SHAM stimulator (SPR Therapeutics, Cleveland, Ohio): SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator (SPR Therapeutics, Cleveland, Ohio) that does not generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption During First Postoperative Week</title>
          <description>Cumulative opioid dose from days 0-7, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point measured in morphine equivalents</description>
          <units>mg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0" upper_limit="30.0"/>
                    <measurement group_id="O2" value="47.5" lower_limit="25" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Average Pain During First Postoperative Week</title>
        <description>Mean value of the &quot;average&quot; pain scores measured using the numeric rating scale, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain</description>
        <time_frame>Postoperative days 0-7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Average Pain During First Postoperative Week</title>
          <description>Mean value of the &quot;average&quot; pain scores measured using the numeric rating scale, collected on days 0, 1, 2, 3, 4, and 7 for the previous 24 hours at each time point. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.1"/>
                    <measurement group_id="O2" value="3.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption Individual Time Points</title>
        <description>Cumulative opioid dose of previous 24 hours (measured in morphine equivalents)</description>
        <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption Individual Time Points</title>
          <description>Cumulative opioid dose of previous 24 hours (measured in morphine equivalents)</description>
          <units>mg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O2" value="15" lower_limit="0" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="20" lower_limit="10" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="10" lower_limit="0" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="5" lower_limit="0" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Brief Pain Inventory, Short Form (Interference Domain)</title>
        <description>The Brief Pain Inventory (short form) interference domain is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale [0 = no interference; 10 = complete interference]: general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The score is calculated by adding the responses for each individual question resulting in a possible range of 0-70 (higher = worse).</description>
        <time_frame>Postoperative days 3, and 7; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Brief Pain Inventory, Short Form (Interference Domain)</title>
          <description>The Brief Pain Inventory (short form) interference domain is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale [0 = no interference; 10 = complete interference]: general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. The score is calculated by adding the responses for each individual question resulting in a possible range of 0-70 (higher = worse).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="4.5"/>
                    <measurement group_id="O2" value="21.5" spread="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="4.9"/>
                    <measurement group_id="O2" value="19.0" spread="17.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="7.7"/>
                    <measurement group_id="O2" value="6.2" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="3.7"/>
                    <measurement group_id="O2" value="5.8" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Pain at Individual Time Points</title>
        <description>Mean of the &quot;average&quot; pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Average Pain at Individual Time Points</title>
          <description>Mean of the &quot;average&quot; pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.8"/>
                    <measurement group_id="O2" value="4.0" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.4"/>
                    <measurement group_id="O2" value="3.9" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.2"/>
                    <measurement group_id="O2" value="3.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.2"/>
                    <measurement group_id="O2" value="2.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.1"/>
                    <measurement group_id="O2" value="1.9" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.2"/>
                    <measurement group_id="O2" value="1.7" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.6"/>
                    <measurement group_id="O2" value="1.9" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.8"/>
                    <measurement group_id="O2" value="1.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.9"/>
                    <measurement group_id="O2" value="0.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Worst Pain at Individual Time Points</title>
        <description>Median of the worst pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Postoperative days 1, 2, 3, 4, 7, 11, and 15; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Worst Pain at Individual Time Points</title>
          <description>Median of the worst pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="6"/>
                    <measurement group_id="O2" value="7.8" lower_limit="3" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="O2" value="7.5" lower_limit="5" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="6" lower_limit="4" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="4.3" lower_limit="3" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="0" upper_limit="3.5"/>
                    <measurement group_id="O2" value="3.5" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1.5" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Least Pain at Individual Time Points</title>
        <description>Least pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain. Participants were asked &quot;what was the lowest pain within the last 24 hours measured using the 0 to 10 scale, with 0 equal to no pain and 10 equal to the worst imaginable pain&quot;?</description>
        <time_frame>Postoperative days 3 and 7; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Least Pain at Individual Time Points</title>
          <description>Least pain scores of previous 24 hours measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain. Participants were asked &quot;what was the lowest pain within the last 24 hours measured using the 0 to 10 scale, with 0 equal to no pain and 10 equal to the worst imaginable pain&quot;?</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.6"/>
                    <measurement group_id="O2" value="1.4" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.7"/>
                    <measurement group_id="O2" value="0.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.3"/>
                    <measurement group_id="O2" value="0.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.2"/>
                    <measurement group_id="O2" value="0.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Current Pain at Individual Time Points</title>
        <description>Current pain scores at the time of the data-collection phone call measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Postoperative days 3 and 7; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Current Pain at Individual Time Points</title>
          <description>Current pain scores at the time of the data-collection phone call measured on a 0-10 Numeric Rating Scale with 0=no pain and 10=worst imaginable pain</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.7"/>
                    <measurement group_id="O2" value="2.3" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.8"/>
                    <measurement group_id="O2" value="1.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.8"/>
                    <measurement group_id="O2" value="1.0" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.6"/>
                    <measurement group_id="O2" value="0.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Defense and Veterans Pain Rating Score</title>
        <description>Instrument designed to assess pain level specifically for active duty military and Veteran patient populations. It is a Likert scale from 0 (no pain) to 10 (worst imaginable pain).</description>
        <time_frame>Postoperative days 3, and 7; as well as Months 1 and 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peripheral Nerve Stimulation</title>
            <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Defense and Veterans Pain Rating Score</title>
          <description>Instrument designed to assess pain level specifically for active duty military and Veteran patient populations. It is a Likert scale from 0 (no pain) to 10 (worst imaginable pain).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.5"/>
                    <measurement group_id="O2" value="4.2" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.5"/>
                    <measurement group_id="O2" value="2.9" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.4"/>
                    <measurement group_id="O2" value="1.5" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.4"/>
                    <measurement group_id="O2" value="1.2" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 months following surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Peripheral Nerve Stimulation</title>
          <description>ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that DOES generate electric current for 14 days</description>
        </group>
        <group group_id="E2">
          <title>Sham</title>
          <description>SHAM peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator that does NOT generate electric current for 14 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Lead fracture during purposeful removal</sub_title>
                <description>The electrical lead fractured during purposeful removal. The remaining lead fragment is always left in situ and there were no adverse sequelae due to the fragments in the 4-month follow-up period.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Adhesive reaction</sub_title>
                <description>Erythema and irritation developed under the occlusive dressing holding the lead. The dressing and lead were removed and the erythema and irritation resolved without requiring treatment.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brian M. Ilfeld, MD, MS</name_or_title>
      <organization>University of California San Diego</organization>
      <phone>(858) 822-0776</phone>
      <email>m1medeiros@health.ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

